INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15
Reducing Cardiovascular risk by treating chronic kidney dysfuction
Authors Name:
Rakshanda S. Khorjuwenkar
, Hrishikesh S. Kamble , Ajinkya T. Pawar , Salas S. Kamat
Unique Id:
IJSDR2310134
Published In:
Volume 8 Issue 10, October-2023
Abstract:
Chronic kidney disease (CKD) is a complex public health issue with high incidence, prevalence, and expensive management. It is linked to increased cardiovascular events, such as heart attacks, strokes, heart failure, and death, due to the gradual decline in glomerular filtration rate (eGFR). To reduce the frequency of critical cardiovascular events, clinicians should focus on preventing renal function deterioration. Early detection and targeted therapy are crucial to prevent the illness from progressing to severe stages. Most CKD patients were treated for a long time by controlling risk factors like diabetes and hypertension, and using renin-angiotensin aldosterone system inhibitors. However, this approach was only partially successful due to the steady decline in renal function. Innovative antidiabetic medications, such as gliflozins and incretins, have been shown to reduce eGFR, reduction in CKD patients and significantly impact cardiovascular prognosis by lowering clinical incidents.
"Reducing Cardiovascular risk by treating chronic kidney dysfuction", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 10, page no.878 - 885, October-2023, Available :http://www.ijsdr.org/papers/IJSDR2310134.pdf
Downloads:
000338719
Publication Details:
Published Paper ID: IJSDR2310134
Registration ID:209094
Published In: Volume 8 Issue 10, October-2023
DOI (Digital Object Identifier):
Page No: 878 - 885
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn